Following the ban of red dye No. 3 in the United States, experts weigh in on the potential health risks of red dye No. 40, ...
Earlier this month, the U.S. Food and Drug Administration (FDA) announced a public meeting entitled “Interested Parties Meeting: Implementation of ...
Medpage Today on MSN2d
HHS Inspector General Raises Concerns Over FDA's Accelerated ApprovalsOf the 24 drugs, three approvals deviated from the others -- aducanumab; the synthetic hormone hydroxyprogesterone caproate ...
The FDA established its accelerated approval program in 1992 to allow drugs to reach the market quickly for life-threatening ...
The authors write "The Food, Drug and Cosmetic Law Section of the New York State Bar Association is delving into the changing ...
The positions of Robert F. Kennedy Jr. on vaccines and drug companies are well known. His approach to addiction has been far ...
The review, which was spurred by controversy over the FDA's Aduhelm approval, recommends two main changes in agency ...
(MENAFN- EIN Presswire) Novamigra Tx Announces Successful Pre-IND Meeting with FDA for Migraine Prophylaxis Asset VRG-145, Paving Way for Accelerated Clinical Development BUDAPEST, HUNGARY ...
An OIG report zeroed in on what it said were three particularly problematic accelerated approvals: Biogen’s Aduhelm, ...
A list of pharmaceutical representatives at the table when the Biden administration negotiated Medicare drug prices reveals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback